CINCINNATI, May 1, 2013 /PRNewswire/ -- Prasco Laboratories announced today it has signed an exclusive distribution and supply agreement with WellSpring Pharmaceutical Corp. for Phenoxybenzamine Hydrochloride Capsules, USP. As part of the agreement, Prasco, LLC is prepared to immediately market the authorized generic of DIBENZYLINE® (phenoxybenzamine hydrochloride capsules, USP), upon the first U.S., AB-rated generic entrant. The authorized generic will be marketed in the U.S. in 10 mg capsules under the Prasco label.
"We would like to welcome WellSpring Pharmaceutical to Prasco's expanding family of brand partners," stated Prasco chief executive officer, Chris Arington. "Patients and customers alike benefit from WellSpring's commitment to maintaining the supply of brand-identical medication through the Prasco Authorized Generic business model." Arington concluded.
Phenoxybenzamine Hydrochloride Capsules, USP are AB-rated and substitutable for the brand DIBENZYLINE Capsules. DIBENZYLINE Capsules are indicated in the treatment of pheochromocytoma, to control episodes of hypertension and sweating. If tachycardia is excessive, it may be necessary to use a beta-blocking agent concomitantly. For more information on Phenoxybenzamine Hydrochloride Capsules USP, including the prescribing information, visit prasco.com.
DIBENZYLINE is a registered trademark of WellSpring Pharmaceutical Corporation.
About WellSpring Pharmaceutical Corp. WellSpring Pharmaceutical Corp. is a privately held pharmaceutical company founded in 1999. WellSpring has made the development, marketing and sales of niche prescription and OTC drug products its strategic focus. The firm actively acquires pharmaceutical brands and enhances their value through the development of product improvements and line extensions. The company recognizes the enduring therapeutic value of these products for smaller groups of patients. WellSpring continues to acquire, produce and market a variety of over-the-counter and prescription products in both the United States and Canada. WellSpring owns and operates an FDA approved manufacturing plant in Oakville, Ontario, Canada. Its administrative headquarters are located in Sarasota, Florida. For more information, visit http://www.wellspringpharm.com.
About Prasco Laboratories Prasco, the Authorized Generic Company, is the privately held healthcare company located in Mason, Ohio. The leader in Authorized Generics, Prasco has more Authorized Generic partnerships than any other company. Established brand companies rely on Prasco to bring their brand products to the generic marketplace as Authorized Generics, which offers alternatives to consumers and pharmacists. For more information, visit prasco.com.
SOURCE Prasco Laboratories